AllianceBernstein’s Pharvaris PHVS Stock Holding History

AllianceBernstein’s Portfolio PHVS Stock Details PHVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$249K	Hold	8,980	–	–	﹤0.01%	2961
2025 Q4	$249K	Hold	8,980	–	–	﹤0.01%	2981
2025 Q3	$224K	Buy	+8,980	New	+$199K	﹤0.01%	3045

Other funds holding PHVS

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

EFM

EQT Fund Management Luxembourg $1.02B AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

AllianceBernstein's PHVS Position: Q1 2026 in Review

AllianceBernstein held its Pharvaris (PHVS) position steady in Q1 2026 at 8,980 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #2961.

AllianceBernstein first reported a position in PHVS in Q3 2025 and has held it in 3 quarters since. 110 funds tracked by Wall St. Rank hold PHVS as of Q1 2026.

AllianceBernstein held 8,980 shares of Pharvaris worth $249K as of Q1 2026.
AllianceBernstein left its Pharvaris share count unchanged in Q1 2026.
Pharvaris made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2961 holding.
AllianceBernstein first reported a position in Pharvaris in Q3 2025 and has held it in 3 quarters since.
110 funds tracked by Wall St. Rank held Pharvaris as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.